Ceftaroline: A new broad-spectrum cephalosporin
- Ceftaroline: Potential role and implications in an era of escalating antimicrobial resistance. Chahine, Elias B. // American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p489
No abstract available.
- PREVALENCE OF HETEROGENEOUS GLYCOPEPTIDE INTERMEDIATE RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS. Chaudhary, Manu; Payasi, Anurag // American Journal of Infectious Diseases;2013, Vol. 9 Issue 3, p63
Multidrug resistant Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial and community acquired infections and is on the rise. The aim of this investigation was to explore the prevalence of MRSA and heterogeneous Glycopeptide Intermediate Staphylococcus aureus...
- Ceftobiprole: An Emerging Therapeutic Option for Resistant and Complicated Infections. Reygaert, Wanda C. // Clinical Medicine Insights: Therapeutics;2011, Issue 3, p57
Ceftobiprole is a new parenterally administered fifth generation cephalosporin which has been shown to have antimicrobial activity against a broad range of bacteria, and specifically against methicillin-resistant Staphylococcus aureus (MRSA) in complicated skin and skin structure infections...
- Why is MRSA so virulent? Goyal, Nitin; Parvizi, Javad // Orthopedics Today;Nov2010, Vol. 30 Issue 11, p45
The article discusses the virulence of methicillin-resistant Staphylococcus aureus (MRSA) in infection prevention and treatment before, during and after orthopedic procedures.
- Case report of a methicillin- and multi-resistant, mecA positive, Staphylococcus saprophyticus and retrospective review of 2011-2012 isolates. Creighton, Julie A.; Anderson, Trevor P. // New Zealand Journal of Medical Laboratory Science;Nov2013, Vol. 67 Issue 3, p104
No abstract available.
- Antimicrobial Resistance of Staphylococcus aureus Isolates in Malaysian Tertiary Hospital. Al-Talib, Hassanain; Al-Khateeb, Alyaa; Hassan, Habsah // International Medical Journal;Apr2015, Vol. 22 Issue 2, p73
Background: Staphylococcus aureus is a frequent cause of hospital anti community-acquired infections globally. Antimicrobial resistance is able to provide results within 24 h and is suitable for use in the diagnostic laboratory. The aim of the present study was to show a representative picture...
- Antibiotic Collateral Damage: Resistance and Antibiotic-Associated Diarrhea. Matsuura, Gregory T.; Garrison, Mark W. // Hospital Pharmacy;Oct2011, Vol. 46 Issue 10, p758
The purpose of this review is to describe dilemmas associated with antibiotic collateral damage and provide clinical pharmacists with information to improve antibiotic utilization. The clinical use of antibiotics has been associated with acquisition and spread of nosocomial pathogens and...
- Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model. Jacqueline, Cédric; Caillon, Jocelyne; Batard, Eric; Le Mabecque, Virginie; Amador, Gilles; Yigong Ge; Biek, Donald; Potel, Gilles // Journal of Antimicrobial Chemotherapy (JAC);Oct2010, Vol. 65 Issue 10, p2264
The article discusses a study on the in vivo efficacy of ceftaroline fosamil against a methicillin-resistant Staphylococcus aureus (MRSA) strain in a rabbit endocarditis model. It explains that ceftaroline fosamil is a form of broad-spectrum cephalosporin demonstrating bactericidal capability...
- learning zone assessment: MRSA. // Nursing Standard;1/5/2011, Vol. 25 Issue 18, p58
A quiz on methicillin-resistant staphylococcus aureus infections is presented.